In addition, PTX still acted as a persistent disincentive to pulmonary fibrosis progression after mice stopped PTX treatment on day 14, with only Col1a1 and Acta2 genes showing slight recovery on day 28 (Figures 3B,C). Here, ACTA2 is linked to pulmonary fibrosis.